Otsuka Holdings Co., Ltd. (OTSKY)
OTCMKTS
· Delayed Price · Currency is USD
23.86
+0.12 (0.51%)
Feb 21, 2025, 3:00 PM EST
Otsuka Holdings Revenue
In the year 2024, Otsuka Holdings had annual revenue of 2.33T JPY with 15.42% growth. Otsuka Holdings had revenue of 599.79B in the quarter ending December 31, 2024, with 11.18% growth.
Revenue
2,329.86B JPY
Revenue Growth
+15.42%
P/S Ratio
n/a
Revenue / Employee
67.75M JPY
Employees
34,388
Market Cap
25.85B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
| Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
| Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
| Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
| Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
Otsuka Holdings News
- 7 days ago - Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript - GuruFocus
- 10 days ago - Otsuka Holdings reports FY results - Seeking Alpha
- 4 months ago - Otsuka Holdings Co., Ltd. reports Q3 results - Seeking Alpha
- 4 months ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg